Advanced glycation end products suppress osteoblastic differentiation of stromal cells by activating endoplasmic reticulum stress

作者：Tanaka Ken ichiro^*; Yamaguchi Toru; Kaji Hiroshi; Kanazawa Ippei; Sugimoto Toshitsugu

来源：Biochemical and Biophysical Research Communications, 2013, 438(3): 463-467.

DOI：10.1016/j.bbrc.2013.07.126

• Advanced glycation end products
• Endoplasmic reticulum stress
• Stromal cells
• Osteoblastogenesis
• Diabetes
• Bone

Advanced glycation end products (AGES) are involved in bone quality deterioration in diabetes mellitus. We previously showed that AGE2 or AGE3 inhibited osteoblastic differentiation and mineralization of mouse stromal ST2 cells, and also induced apoptosis and decreased cell growth. Although quality management for synthesized proteins in endoplasmic reticulum (ER) is crucial for the maturation of osteoblasts, the effects of AGEs on ER stress in osteoblast lineage are unknown. We thus examined roles of ER stress in AGE2- or AGE3-induced suppression of osteoblastogenesis of ST2 cells. An ER stress inducer, thapsigargin (TG), induced osteoblastic differentiation of ST2 cells by increasing the levels of Osterix, type 1 collagen (Coil), alkaline phosphatase (ALP) and osteocalcin (OCN) mRNA. AGE2 or AGE3 suppressed the levels of ER stress sensors such as IRE1 alpha, ATF6 and OASIS, while they increased the levels of PERK and its downstream molecules, ATF4. A reduction in PERK level by siRNA did not affect the AGEs-induced suppression of the levels of Osterix, Coll and OCN mRNA. In conclusion, AGEs inhibited the osteoblastic differentiation of stromal cells by suppressing ER stress sensors and accumulating abnormal proteins in the cells. This process might accelerate AGEs-induced suppression of bone formation found in diabetes mellitus.

• 出版日期2013-8-30